EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Synergistic antitumor effects of astragalus polysaccharide: a preclinical systematic review and meta-analysis

Ruo Zhang, Qian Yang, Zhi Chen, Jianming Huang, Guonan Zhang

Frontiers in Pharmacology · 18.12.2025 · 16

DOI: 10.3389/fphar.2025.1672450 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Frontiers in Pharmacology, online erschienen am 18.12.2025. Verfasst von Ruo Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Accumulating evidence suggests that astragalus polysaccharide (APS) may enhance the efficacy of conventional cancer therapies through multiple mechanisms. However, the synergistic effects of APS have not been systematically quantified. This meta-analysis was therefore conducted to quantify these potential synergistic antitumor effects and provide preclinical evidence to inform future clinical trials.

Methods

Following PRISMA 2020 guidelines, we systematically searched ten databases (including PubMed and Web of Science) for preclinical studies from inception to May 2025 using predefined inclusion criteria. Risk of bias was assessed using SYRCLE’s RoB tool. Meta-analyses and subgroup analyses were performed using RevMan 5.4.1, while publication bias was assessed via funnel plots and Egger’s test (Stata 17.0). This systematic review was prospectively registered in PROSPERO (registration number: CRD420251047751).

Results

Forty-one publications (44 independent studies) involving 748 animals were included. APS combination therapy was associated with significant improvements in tumor-related outcomes, including reduced tumor weight and volume, suppressed metastasis, and prolonged survival. Mechanistically, APS co-administration enhanced CD8 + T-cell infiltration, increased splenic and thymic indices, modulated cytokine profiles (TNF-α, IL-2, IFN-γ, IL-12, IL-6, IL-10), and reduced PD-1/PD-L1 expression in tumor tissue. Additionally, APS appeared to alleviate chemotherapy-induced nephrotoxicity, as evidenced by lower serum creatinine levels. Subgroup analyses indicated that heterogeneity was partially explained by model type, APS dosing regimen, and combination therapy modality. The certainty of evidence for primary outcomes was rated as low or very low according to the GRADE assessment.

Conclusion

This meta-analysis provides preclinical evidence that APS may serve as an adjunctive agent to enhance the efficacy of conventional cancer therapies. However, given the low certainty of current evidence, further mechanistic studies and well-designed clinical trials are urgently warranted to establish its efficacy and therapeutic role in oncology. Systematic Review Registration PROSPERO 2025 CRD420251047751 https://www.crd.york.ac.uk/PROSPERO/view/CRD420251047751

Schlagwörter

Stichwörter der Autor:innen

antitumorastragalus polysaccharidemeta-analysispreclinical studiestraditional Chinese medicine

Autor:innen und Institutionen

  • College of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Department of Biochemistry and Molecular Biology, Sichuan Cancer Hospital and Institute, Chengdu, China.
  • Department of Gynecologic Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China.

Zitieren

APA

Zhang, R., Yang, Q., Chen, Z., Huang, J., & Zhang, G. (2025). Synergistic antitumor effects of astragalus polysaccharide: a preclinical systematic review and meta-analysis. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1672450

Vancouver

Zhang R, Yang Q, Chen Z, Huang J, Zhang G. Synergistic antitumor effects of astragalus polysaccharide: a preclinical systematic review and meta-analysis. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1672450

BibTeX
@article{Zhang2025,
  author = {Zhang, Ruo and Yang, Qian and Chen, Zhi and Huang, Jianming and Zhang, Guonan},
  title = {Synergistic antitumor effects of astragalus polysaccharide: a preclinical systematic review and meta-analysis},
  journal = {Frontiers in Pharmacology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fphar.2025.1672450}
}
Kostenlos starten →